Casdin Capital, LLC Portfolio Holdings

Casdin Capital, LLC

  • $713 Million
  • Q2 2025

Casdin Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $713 Million distributed in 33 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $166M, Revolution Medicines, Inc. with a value of $106M, Standard Biotools Inc. with a value of $91.3M, Illumina, Inc. with a value of $61.5M, and Avidity Biosciences, Inc. with a value of $50.4M.

Examining the 13F form we can see an decrease of $141M in the current position value, from $855M to 713M.

Casdin Capital, LLC is based out at New York, NY

Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $713 Million
Healthcare: $698 Million
Consumer Defensive: $11.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.03B
$166 Million 23.27% of portfolio
7,707,165
Q2 2025 Reduced 11.48%
$3.09B
$106 Million 14.89% of portfolio
2,887,933
Q2 2025 Reduced 21.9%
$103M
$91.3 Million 12.8% of portfolio
76,075,636
Q1 2025 Added 6.77%
$15.3B
$61.5 Million 8.63% of portfolio
645,000
Q2 2025 Added 8.4%
$2.41B
$50.4 Million 7.07% of portfolio
1,775,000
Q2 2025 Reduced 13.2%
$667M
$46 Million 6.45% of portfolio
4,095,571
Q2 2025 Added 2.5%
$403M
$39.4 Million 5.53% of portfolio
11,398,574
Q2 2025 Added 25.28%
$52.9B
$26.6 Million 3.72% of portfolio
81,500
Q2 2025 Reduced 32.08%
$1.19B
$24.7 Million 3.46% of portfolio
1,450,000
Q2 2025 Added 1.71%
$187M
$17.6 Million 2.46% of portfolio
7,200,000
Q2 2025 Reduced 11.11%
$1.6B
$16.9 Million 2.37% of portfolio
990,097
Q2 2025 Added 9.92%
$1.77B
$12.5 Million 1.75% of portfolio
890,000
Q2 2025 Reduced 10.1%
$9.53B
$11.5 Million 1.61% of portfolio
230,000
Q2 2025 Added 15.0%
$2.06B
$7.47 Million 1.05% of portfolio
276,308
Q4 2024 Reduced 58.53%
$608B
$6.63 Million 0.93% of portfolio
8,500
Q2 2025 New
$734M
$6.09 Million 0.85% of portfolio
650,000
Q2 2025 Added 2.36%
$7.33B
$4.78 Million 0.67% of portfolio
90,000
Q2 2025 Reduced 77.78%
$363M
$3.87 Million 0.54% of portfolio
1,567,175
Q2 2025 Added 326.82%
$1.94B
$3.33 Million 0.47% of portfolio
100,000
Q2 2025 Reduced 60.0%
$276M
$2.5 Million 0.35% of portfolio
973,260
Q3 2023 Reduced 28.87%
$272M
$897,000 0.13% of portfolio
723,767
Q1 2025 Reduced 30.13%
$976M
$836,000 0.12% of portfolio
165,323
Q4 2024 New
$30.6M
$687,000 0.1% of portfolio
1,228,190
Q2 2025 Reduced 61.77%
$208M
$387,000 0.05% of portfolio
86,014
Q3 2024 Reduced 67.05%
$31.4M
$220,000 0.03% of portfolio
361,969
Q2 2025 Reduced 94.62%
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 50.0%
Genedx Holdings Corp
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.55%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 75.0%
Ginkgo Bioworks Holdings Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Maze Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 19.81%
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 146.92%

Summary

  • Portfolio
  • No. of Stocks 33
  • Current Value $713 Million
  • Prior Value $855 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email